Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical companies, which includes the makers of Xarelto, possess a duty to make sure that their drugs are reasonably protected for use - and failure to perform so might be grounds for compensation. Our lawyers are operating hard to get those hurt by the drug the compensation they are entitled to.













Whilst bleeding is really a common complication related with anticoagulants, it has been alleged that Xarelto is much more hazardous than conventional blood thinners because no antidote exists to reverse its blood-thinning effects. This indicates that, in the occasion of an emergency, patients might be at risk for irreversible bleeding troubles, which includes life-threatening internal and gastrointestinal hemorrhaging.













If you or perhaps a loved one particular suffered a significant bleeding occasion right after taking Xarelto, you may have legal recourse. For a lot more details, speak to us nowadays to possess your case reviewed, totally free of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future health-related bills, lost wages, discomfort and suffering and, in instances of death, funeral expenditures. Moreover, they may be looking for punitive damages, which are typically awarded to punish the defendant and deter other firms from acting similarly.






Why Are Lawsuits Becoming Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective ec-helpdesk.com means of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs within the lawsuits allege severe and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a secure anticoagulant option.






Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.






Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.













Visit this page for a lot more data on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki